Proton Beam Therapy Reduced Bone Marrow Suppression Compared with IMRT for Patients with Stage III NSCLC Receiving Concurrent Chemotherapy

Reviewer: Curtiland Deville, MD
The Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 28 de mayo del 2010

Translation for this article does not exist